Matches 1 - 50 out of 64 1 2 >


Match Document Document Title
US20110014656 SOLUBLE IL-17RA/RC FUSION PROTEINS AND RELATED METHODS  
Disclosed are antagonists of IL-17A and IL-17F. The antagonists are based on soluble IL-17RA and IL-17RC fusion proteins, including hybrid soluble receptors comprising portions of both IL-17RC and...
US20140044739 CDIM Binding Proteins And Uses Thereof  
The present disclosure relates to Cell Death Inducing Molecule (“CDIM”) binding proteins and pharmaceutical compositions thereof. Particularly, the disclosure provides CDIM binding proteins that...
US20150072368 TRANSCRIPTION UNITS AND THE USE THEREOF IN EXPRESSION VECTORS  
Novel transcription units that may be used in expression vectors. The transcription unit allow antibodies to be produced whose gain in productivity is not linked to a particular antigenic target...
US20140314832 LUNG-TARGETING NANOBODIES AGAINST PULMONARY SURFACTANT PROTEIN A AND THEIR PREPARATION  
The present invention relates to pharmaceutical and medical technologies, and more particularly to novel nanobodies against pulmonary surfactant protein A (SP-A) and their preparation methods. The...
US20110223684 DETECTION OF SPECIFIC NITRATED MARKERS  
Methods are described for improving the diagnostic possibilities of diseases where oxidative NO-modifications occur, for example inflammatory conditions, cancer, Parkinson's or Alzheimer's...
US20140093915 IL-18 RECEPTOR ANTIGEN BINDING PROTEINS  
Provided herein are IL-18 receptor antigen binding proteins and polynucleotides encoding the same. Expression vectors and host cells comprising the same for production of the antigen binding...
US20130108644 Inhibition of AXL Signaling in Anti-Metastatic Therapy  
Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL protein activity, for...
US20050042747 Hivgp120-induced bob/gpr15 activation  
Disclosed are compositions and methods for reducing the interaction between gp120 and Bob.
US20060292693 Monoclonal antibody with the capability of neutralizing enterovirus type 71 infection  
The present invention provides a monoclonal antibody capable of neutralizing EV71 infection.
US20060003343 Primer and probe design for efficient amplification and detection of HCV 3' non-translating region  
The present invention provides selected oligonucleotides corresponding to portions of the 3′ non-translating region of Hepatitis C virus. The invention also includes methods of detecting and of...
US20130059825 Antibodies to 25-HYDROXY Vitamin D2 and D3 and Uses Thereof  
Provided herein are antigenic molecules that can be used to generate antibodies capable of binding to a vitamin D derivative, such as 25-hydroxyvitamin D2 and/or 25-hydroxyvitamin D3, or a...
US20120015380 ANTI-POLYETHYLENE GLYCOL ANTIBODY EXPRESSING CELL QUANTIFY ANY FREE POLYETHYLENE GLYCOL AND POLYETHYLENE GLYCOL-DERIVATIZED MOLECULES  
In this invention, anti-PEG antibodies or anti-methoxyl-PEG (anti-CH3O-PEG) antibodies were expressed on cell surface which can collocate with a biotinylated anti-PEG antibody (AGP4-Biotin) or...
US20140336156 ANTIBODIES TO 25-HYDROXYVITAMIN D2 AND D3 AND USES THEREOF  
Provided herein are antigenic molecules that can be used to generate antibodies capable of binding to a vitamin D derivative, such as 25-hydroxyvitamin D2 and/or 25-hydroxyvitamin D3, or a...
US20100062542 ANTIBODY AGAINST AFLATOXINS, SUPPORT USING THE ANTIBODY, METHOD OF IMMUNOLOGICALLY DETECTING AFLATOXINS AND METHOD OF CONCENTRATING AND PURIFYING AFLATOXINS  
It is intended to detect, concentrate and purify aflatoxins of all types which are possibly contained in a sample such as a food. It is also intended to detect the total amount or the individual...
US20070196902 Method of detecting AZT resistance in HIV  
Described herein is a method of determining the presence of a nucleoside reverse transcriptase inhibitor-resistant Human Immunodeficiency Virus-1 (HIV-1) virus particle in a biological sample,...
US20150232577 ANTI-BIOTIN ANTIBODIES AND METHODS OF USE  
The invention provides anti-biotin antibodies and methods of using the same.
US20070099276 Retrovirus-like particles and retroviral vaccines  
The invention relates to retrovirus-like particles having an altered nucleocapsid domain that inhibits packaging of genomic RNA into the retrovirus-like particle, and a protease having reduced...
US20150238628 ANTI-THEOPHYLLINE ANTIBODIES AND METHODS OF USE  
The invention provides anti-theophylline antibodies and methods of using the same.
US20120027782 MONOCLONAL ANTIBODY PARTNER MOLECULE CONJUGATES DIRECTED TO PROTEIN TYROSINE KINASE 7 (PTK7)  
The present disclosure relates to antibody-partner molecule conjugates directed to PTK7. Also described are methods for treating or preventing a disease characterized by growth of tumor cells...
US20110052608 NOVEL ANTIBODIES AGAINST PRION PROTEIN AND USES THEREOF  
The present invention relates to a novel antibody which selectively binds to the disease associated form of prion protein (PrPSc) under native conditions and the use thereof in methods of prion...
US20130195872 ANTI-IL-17A/IL-17F CROSS-REACTIVE ANTIBODIES AND METHODS OF USE THEREOF  
This invention provides fully human monoclonal antibodies that recognize IL-17F, the IL-17F homodimer, IL-17A, the IL-17A homodimer, and/or the heterodimeric IL-17A/IL-17F protein complex. The...
US20060205070 HIV TEV compositions and methods of use  
The disclosure encompasses p28TEV polypeptide, polynucleotides, variants, and antagonists. p28TEV polypeptides and/or polynucleotides are useful in immunogenic compositions. p28TEV polypeptide...
US20120100158 ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME  
A hybridoma cell which has been deposited under ATCC Accession Number PTA-9974 is disclosed. Also provided are Antibodies and methods of using same.
US20140186377 PROSTAGLANDIN E2 BINDING PROTEINS AND USES THEREOF  
The present invention encompasses prostaglandin E2 (PGE2) binding proteins. The invention relates to antibodies that are wild-type, chimeric, CDR grafted and humanized. Preferred antibodies have...
US20070092898 Detection of multiple anti-viral antibodies  
The present invention relates to methods and kits for the diagnosis and monitoring of hepatitis C virus (HCV) infection and/or Kaposi's sarcoma herpesvirus infection (KSHV) in a subject, as well...
US20130189283 CARRIER IMMUNOGLOBULINS AND USES THEREOF  
Disclosed is an isolated immunoglobulin. Also disclosed are pharmaceutical compositions and medicaments comprising the immunoglobulin, isolated nucleic acid encoding it, vectors, host cells,...
US20130295095 MONOCLONAL ANTIBODIES TARGETING AMYLOID BETA OLIGOMERS  
The invention relates to binding molecules capable of specifically recognizing soluble oligomers of N-terminal truncated Aβ starting with pyroglutamate (AβρE), pharmaceutical compositions...
US20110280884 ANTI-CD98 ANTIBODY  
A human antibody or a functional fragment thereof having specific binding ability to CD98 which is derived from the cell membrane of cancer cells and is in the form of a complex with a protein...
US20150044236 CARRIER IMMUNOGLOBULINS  
Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the...
US20150044235 CARRIER IMMUNOGLOBULINS  
Disclosed is an isolated antigen binding protein, such as but not limited to, an antibody or antibody fragment. Also disclosed are pharmaceutical compositions and medicaments comprising the...
US20060194244 Uses of a chemokine receptor for inhibiting HIV-1 infection  
This invention provides a polypeptide comprising a fragment of a chemokine receptor capable of inhibiting HIV-1 infection. In an embodiment, the chemokine receptor is C-C CKR-5. In another...
US20120045443 Agonist anti-trk-c monoclonal antibodies  
The invention concerns agonist anti-trkC monoclonal antibodies which mimic certain biological activities of NT-3, the native ligand of trkC. The invention further concerns the use of such...
US20070105218 Lupus antibodies for passive immunotherapy of hiv/aids  
Disclosed are monoclonal antibodies and antibody fragments which recognize antigens encoded by HERV DNA sequences, and methods for production, including recombinant antibody fragments derived from...
US20060188982 Multiplexed analysis for determining a serodiagnosis of viral infection  
Clinical samples can be analyzed using microparticles to determine the serodiagnosis of a viral infection from two candidate viral infections of the same viral group. Serodiagnosis can be...
US20130317201 ANTI-CDH3 ANTIBODY HAVING HIGH INTERNALIZATION CAPACITY  
It is an object of the present invention to provide an anti-cadherin antibody having a high internalization capacity and provide an anti-cadherin antibody-drug conjugate that effectively kills...
US20070154468 Use of CD28-specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections  
The invention teaches the application of monoclonal antibodies being specific for CD28 and activating T lymphocytes of several to all sub-groups without occupying an antigen receptor of the T...
US20100310597 ANTI-OFLOXACIN MONOCLONAL ANTIBODY AND IMMUNOASSAY OF OFLOXACIN USING THE SAME  
A method that accurately and conveniently detects a compound shown by the formula (I) in a human sample is disclosed. An antibody that reacts with the compound shown by the formula (I), but does...
US20060263802 Antigenic peptides of rabies virus and uses thereof  
The present invention pertains to antigenic peptides of rabies virus and their use in the detection, prevention and/or treatment of conditions resulting from rabies virus.
US20130287799 ABETA CONFORMER SELECTIVE ANTI-ABETA GLOBULOMER MONOCLONAL ANTIBODIES  
The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies...
US20110020219 Anti-human tenascin monoclonal antibody  
A novel anti-human tenascin ST2146 monoclonal antibody is described endowed with high affinity with the native antigen and high tumor selectivity. The cST2146 hybridoma is stably producing the...
US20090221066 Anti-Methylated Dna Antibody and Method for Production Thereof  
The present invention provides a method of preparing an anti-methylated DNA antibody, comprising a step of administering to an animal an oligodeoxyribonucleotide containing a methylated...
US20110305715 ANTIBODIES TO 3-HYDROXYCOTININE AND METHODS OF USE THEREOF  
The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to 3-hydroxycotinine (3HC). The invention also provides compositions containing these antibodies...
US20070099296 Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs  
The present invention provides methods for determining the susceptibility of a pathogenci flavirus to anti-viral compounds. This invention also provides methods for determining anti-viral drug...
US20140349319 ANTIBODY SPECIFIC FOR TRANS-RESVERATROL AND USE THEREOF  
The present invention provides a method of detecting or measuring trans-Resveratrol (tRV) in a sample, comprising: contacting a sample to be tested with an antibody against tRV, or an antigen...
US20140193413 ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES  
The present disclosure relates to an antibody or antibody fragment capable of binding to phosphorylcholine and/or a phosphorylcholine conjugate, wherein the antibody or antibody fragment comprises...
US20140030271 HMGB1 SPECIFIC MONOCLONAL ANTIBODIES  
The present invention concerns monoclonal antibodies specifically binding the human HMGB1 protein and further HMGB1 proteins of mammalian origin and also concerns fragments thereof, nucleic acids...
US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes  
The invention relates to the use of a compound that binds to a C-type lectin on the surface of a sinusoid endothelial layer, in the preparation of a composition for modulating, in particular...
US20140271688 ANTIBODY DRUG CONJUGATES  
The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
US20080050381 Antihuman Baff Antibody  
An antibody against a peptide having an amino acid sequence AVQGPEETVT QDC (expressed in single letter amino acid code) corresponding to the 134- to 146-positions in human BAFF (B cell activating...
US20090280128 ANTI-ILT7 ANTIBODY  
An antibody binding to IPC was obtained by using an animal cell in which a cell membrane protein associatable with ILT7 was co-expressed as an immunogen. The antibody of the invention has a high...

Matches 1 - 50 out of 64 1 2 >